Ephion Health
- Company typePrivate
- Founded2021
- HeadquartersBarcelona, Spain
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
Ephion Health firmographics
Firmographics- Name
- Ephion Health
- Legal name
- EPHION HEALTH SL
- Website
- https://ephion.health
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Ephion Health industry classification
Industry- Product category
- Digital Health Software
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Services-Prepackaged Software (7372), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- SaMD – Digital Biomarkers & Algorithmic Endpoints (HLACANAF)
Keywords
Where Ephion Health is headquartered
LocationHeadquarters
- HQ city
- Barcelona
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
Ephion Health business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Others
Revenue model
- Software Licensing / Subscription (Ephion Mobility): Ephion Mobility is a Medical Device Software (MDSW) sold to healthcare institutions. Revenue is generated through software licensing or subscription fees for access to the platform, dashboard, and biomarker analysis capabilities. The platform is targeted at hospitals and rehabilitation centres for use by healthcare professionals.
- Pharmaceutical Research Services: Ephion provides digital endpoints for clinical trials, contributing to patient recruitment, stratification, retention, and decentralized clinical trial support for pharmaceutical companies. This is a B2B service model.
- Ephion Research Platform: A disease-agnostic system offered to researchers and institutions for capturing patient data and exploring new measures and biomarkers, likely sold as a research tool license.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels9 records
Ephion Health product offering
Product offeringCore offering
Ephion Health develops and sells an AI-powered digital biomarker platform that integrates third-party wearable sensor data, clinical reports, and patient-reported outcomes to generate composite functional capacity scores. The platform is offered as regulated Medical Device Software (MDSW) to hospitals, rehabilitation centres, and pharmaceutical companies for objective assessment of patients with neurological, neuromuscular, and musculoskeletal conditions, as well as a disease-agnostic research tool for clinical investigators.
Product overview
Ephion Health offers a platform-based product portfolio centered on digital biomarkers for objective functional capacity assessment. The core offerings include Ephion Mobility (clinically validated medical device software for neuromuscular diseases), Ephion Vitality (in development for frailty assessment), and Ephion Research (disease-agnostic research tool). The platform integrates data from third-party wearables, clinical reports, and patient-reported outcomes, processing them through AI algorithms to generate composite functional capacity scores delivered via a clinician web portal. All products share the same underlying data capture infrastructure and AI analysis engine.
Differentiator
Problem solved
Functional benefit
Brands
- Ephion Mobility: Clinically validated tool for objective and comprehensive assessment of patients with neurological, neuromuscular or musculoskeletal disorders. Medical Device Software (MDSW) intended for patients with conditions affecting mobility, stance, gait or balance including DMD, BMD, MMD, LOPD, CIDP, and Anti-MAG neuropathy.
- Ephion Vitality
- Ephion Research
- Ephion Care App
Products and services
- Ephion Mobility A clinically validated Medical Device Software (MDSW) that processes biomechanical data from third-party wearable sensors to generate features and a composite functional capacity score, providing an objective indicator of disease progression and treatment response for ambulant patients with neurological, neuromuscular, or musculoskeletal disorders.
- Ephion Care App A mobile application enabling patient disease monitoring through questionnaires and recording of patient physical activity. Exclusively for registered healthcare professional users to support clinical assessment.
- Ephion Research A disease-agnostic, easy-to-use system with all tools needed to start capturing patient data and explore new digital measures and biomarkers, designed for researchers investigating digital endpoints across various disease areas.
- Ephion Vitality A solution in development for the assessment of frail elderly patients, designed to provide precise measurement of risk of falling as part of the company's functional capacity evaluation portfolio.
Quantifiable outcome
- Composite functional capacity score providing objective, quantitative patient assessment
- +3 more outcomes
Companies that use Ephion Health
Customer profileSegments3 records
Ideal customer profiles3 records
Ephion Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature5 records
Ephion Health partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core, major and minor.
- IHI Project PALADINcoreEphion Health officially joined the Innovative Health Initiative (IHI) Project PALADIN, a €21 million European consortium dedicated to transforming rare disease care. Ephion integrates its AI-powered digital biomarker platform with PALADIN's 'Interactium' technology to contribute expertise in objective functional assessment and wearable data analysis. The collaboration aims to bridge gaps in patient data for neuromuscular diseases, empowering patients and providing researchers with real-world evidence to accelerate development of life-changing treatments.
- DEEP EcosystemcoreEphion Health became a member of the DEEP (Deep Measures in Progressive Diseases) ecosystem, collaborating with other digital health innovation leaders. The partnership provides access to expert resources, tools, networking opportunities, and collaborative projects aimed at advancing digital measures in clinical trials and beyond, enhancing Ephion's ability to deliver solutions that improve patient outcomes.
- DayOne Basel - Healthcare InnovationmajorEphion was selected as one of 15 companies for the 2024 Cohort 6 of the DayOne Basel Healthcare Innovation program. The program, based in Basel (home to many leading pharmaceutical companies), provides mentorship and facilitates connections between digital health startups and pharma decision-makers, focusing on solutions that accelerate time-to-market and optimize clinical trial processes.
- ICEX (Spain Trade and Investment)minorICEX hosted Ephion Health at the Spain booth at HLTH Europe in Amsterdam, providing international visibility and market access support for Spanish digital health companies.
- EURECATcoreEphion Health was founded as a spin-off of EURECAT (a leading technology centre in Spain). EURECAT's Health Tech unit, led by co-founder Felip Miralles, provided the research foundation and technical expertise for Ephion's digital biomarker platform.
- Hospital Sant Joan de DéucoreEphion Health was founded as a spin-off of Hospital Sant Joan de Déu (a leading pediatric hospital in Barcelona). The hospital provided clinical research expertise and domain knowledge in neuromuscular and pediatric conditions, forming the clinical foundation of Ephion's platform.
- Google HealthminorEphion met with the Google Health team at HLTH Europe in Amsterdam, establishing a connection for potential collaboration in the digital health space.
Scale indicators7 records
Recent moves7 records
Expansion highlights6 records
Ephion Health competitors and assessment
Company assessmentDirect peers
- Koneksa Health: Koneksa Health is a direct competitor offering digital biomarker and wearable-based clinical outcome assessment solutions for pharma-sponsored clinical trials. Like Ephion, it generates validated digital endpoints from wearable sensor data and serves pharma R&D, making it the closest comparable in business model and target customer.
- ActiGraph: ActiGraph is a leading provider of wearable activity monitors and digital health technology for clinical research, directly overlapping with Ephion's wearable-based mobility assessment. Both companies provide validated endpoints for clinical trials in neuromuscular and chronic disease populations.
- VivoSense: VivoSense develops wearable sensor-based digital endpoints for clinical trials and patient monitoring, with regulatory-grade algorithms analogous to Ephion Mobility. Both companies serve pharma with objective functional and mobility outcomes.
- IXICO: IXICO specialises in digital biomarkers and imaging analytics for neurological disease clinical trials. It shares Ephion's niche focus on neurological and neuromuscular endpoints and is a credible comparator in disease-specific biomarker validation.
- Sysnav Healthcare: Sysnav Healthcare develops wearable sensors and digital outcome measures for neuromuscular disease trials, including Duchenne muscular dystrophy — a direct overlap with Ephion Mobility's flagship indications.
Broad incumbents
- Clario: Clario (formerly ERT/Bioclinica) is a broad incumbent in clinical trial endpoint technology, including wearable-derived digital endpoints. It competes with Ephion for pharma R&D budget but offers a much wider portfolio of trial technologies.
- Medidata (Dassault Systèmes): Medidata offers the Sensor Cloud Network and decentralized trial platform integrating wearables and digital biomarkers. As a large incumbent in eClinical solutions, it competes with Ephion for pharma endpoint contracts at a global scale.
- Biofourmis: Biofourmis offers AI-driven remote patient monitoring and digital biomarkers across multiple therapeutic areas including oncology and cardiology. It is broader than Ephion but competes in the same wearable-data-to-endpoint value chain for pharma and providers.
- Roche (digital biomarker initiatives): Roche and its subsidiaries (e.g., Genentech, Roche Diagnostics) invest heavily in digital biomarker platforms for clinical trials and are both potential customers and competitors of Ephion. They represent the pharma-side demand Ephion targets.
Emerging players
- Byteflies: Byteflies is a Belgian health-tech startup developing wearable-derived digital biomarkers, with overlap in neurological and rare-disease patient monitoring. Like Ephion, it is an emerging European player targeting pharma trial endpoints.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks7 records
Key highlights6 records
Customer concentration
Ephion Health social profiles
Digital presenceEphion Health compliance and trust
Trust signalCompliance3 records
Ephion Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ephion Health leadership team
Management profileNumber of profiles
Profiles8 records
Ephion Health funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ephion Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ephion Health
What does Ephion Health do?
Ephion Health develops and sells an AI-powered digital biomarker platform that integrates third-party wearable sensor data, clinical reports, and patient-reported outcomes to generate composite functional capacity scores. The platform is offered as regulated Medical Device Software (MDSW) to hospitals, rehabilitation centres, and pharmaceutical companies for objective assessment of patients with neurological, neuromuscular, and musculoskeletal conditions, as well as a disease-agnostic research tool for clinical investigators.
Is Ephion Health a public or private company?
Ephion Health is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Ephion Health founded?
Ephion Health was founded in 2021. It employs 1 to 10 people.
Where is Ephion Health based?
Ephion Health is headquartered in Barcelona, Spain, in the Europe region.
How does Ephion Health make money?
Three revenue lines are on record. Software Licensing / Subscription (Ephion Mobility) is the primary driver. The others are pharmaceutical Research Services and ephion Research Platform.
Who are Ephion Health's main competitors?
Direct peers on record are Koneksa Health, ActiGraph, VivoSense, IXICO and Sysnav Healthcare. Broad incumbents are Clario, Medidata (Dassault Systèmes), Biofourmis and Roche (digital biomarker initiatives). Byteflies is listed as an emerging player.
Does Ephion Health have an API?
No public API is recorded for Ephion Health.
What industry is Ephion Health in?
Ephion Health's product category is Digital Health Software. Its primary akta.pro industry code is HLACANAF, SaMD – Digital Biomarkers & Algorithmic Endpoints. Its NAICS code is 334510 and its SIC code is 7372.